choline salicylate: Clinical Trials

2 trials of choline salicylate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1

Follow choline salicylate: new trials by email Literature Review of choline salicylate trials Research Report on choline salicylate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Effects of Oral Ulceration Healing in Patients Wearing a Removable Denture
Chlorhexidine Gluconate, Choline Salicylate 8.7 % Oral Gel, control group - Oral Mucosa; Ulcer
Not applicableCompletedMedical University of Silesia272023-01-012024-08-01
Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma
Choline Salicylate, Selinexor - Recurrent Histiocytic and Dendritic Cell Neoplasm, Recurrent Hodgkin Lymphoma
Phase 1CompletedMayo Clinic222021-02-082026-05-28

Conditions studied

Hodgkin Disease (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Oral Ulcer (1)

Sponsors

Mayo Clinic (1)  ·  Medical University of Silesia (1)

Countries

Poland (1)  ·  United States (1)

Top investigators

Jonas Paludo, MD (1)

NIH funding

P50CA097274 (1)